Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 31;58(4):240-242.
doi: 10.5045/br.2023.2023169. Epub 2023 Nov 30.

Clinico-pathological features and treatment outcomes of high-grade B cell lymphoma-a tertiary cancer center experience

Anindya Mukherjee  1 , Sujay Rainchwar  1 , Aakanksha Singh  1 , Rohan Halder  1 , Pritish Chandra Patra  1 , Rayaz Ahmed  1 , Dinesh Bhurani  1 , Narendra Agrawal  1
Affiliations

Clinico-pathological features and treatment outcomes of high-grade B cell lymphoma-a tertiary cancer center experience

Anindya Mukherjee et al. Blood Res. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Authors’ Disclosures of Potential Conflicts of Interest

No potential conflicts of interest relevant to this article were reported.

References

    1. Chen BJ, Fend F, Campo E, Quintanilla-Martinez L. Aggressive B-cell lymphomas-from morphology to molecular pathogenesis. Ann Lymphoma. 2019;3:1–22. doi: 10.21037/aol.2018.12.02. - DOI
    1. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90. doi: 10.1182/blood-2016-01-643569. - DOI - PMC - PubMed
    1. Perry AM, Crockett D, Dave BJ, et al. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases. Br J Haematol. 2013;162:40–9. doi: 10.1111/bjh.12343. - DOI - PubMed
    1. Moharana L, Dasappa L, Babu S, et al. Comparison between CHOP and DAEPOCH with or without rituximab in adult high grade B cell lymphoma, not otherwise specified; a retrospective study from a tertiary cancer hospital in South India. Indian J Hematol Blood Transfus. 2022;38:15–23. doi: 10.1007/s12288-021-01427-8. - DOI - PMC - PubMed
    1. Karunakaran P, Selvarajan G, Kalaiyarasi JP, et al. Therapeutic outcomes in high-grade B-cell lymphoma, NOS: retrospective analysis. South Asian J Cancer. 2022;11:68–72. doi: 10.1055/s-0041-1739365.64de450a1bbd433aa5769b7566be1ed5 - DOI - PMC - PubMed